Isabella Ciccone

New York

Assistant Editor at MJH Life Sciences

Assistant Editor, @neurology_live 🧠 | @TCNJ Alum 🦁 | Former @rutgersifh Research Assistant 🔬 | 📧 [email protected] | Views are my own.

Featured in: Favicon

mjhlifesciences.com Favicon

hcplive.com Favicon

newsbreak.com Favicon

ajmc.com

contemporaryobgyn.net Favicon

pharmexec.com Favicon

contemporarypediatrics.com Favicon

neurologylive.com Favicon

managedhealthcareexecutive.com Favicon

patientcareonline.com + 3 more

Articles

FDA Grants Authorization to Epiminder’s Implantable Continuous EEG Monitor for Epilepsy Treatment

21 hours ago | neurologylive.com | Isabella Ciccone

According to a new announcement, the FDA has granted De Novo authorization to Epiminder’s Minder, an implantable continuous electroencephalogram monitoring system (iCEM), marking it as the first device of its kind approved in the United States for patients with epilepsy.
Final CHAMPION MG Trial Data Show Sustained Benefit, Safety of Ravulizumab in Myasthenia Gravis

1 day ago | neurologylive.com | Isabella Ciccone

Newly published in the European Journal of Neurology, final results from the open-label extension of the phase 3 CHAMPION MG trial (NCT03920293) assessing ravulizumab (Ultomiris; AstraZeneca) revealed treatment with the agent demonstrated durable efficacy and continued safety in patients with anti-acetylcholine receptor antibody-positive generalized myasthenia gravis (MG).1 These long-term data build on previous findings from the randomized controlled and interim open-label phases of the...
Assessing Clinical Relevancy of Visual Biomarkers in Alzheimer Disease: Alfredo A. Sadun, MD, PhD

2 days ago | neurologylive.com | Alfredo A. Sadun |Isabella Ciccone

CommentaryVideoApril 22, 2025Author(s):,Fact checked by:The chief of ophthalmology at the Doheny Eye Institute discussed decades of research uncovering how Alzheimer can impact visual function and how retinal imaging may advance diagnosis. [WATCH TIME: 13 minutes]WATCH TIME: 13 minutes"We found out that patients [with Alzheimer] do not suffer a loss of acuity nor color vision, but they do suffer losses of stereo, and most of all, contrast sensitivity and orientation.
Real-World Data Show Similar Comorbidity Rates With and Without Sodium Oxybate Treatment

2 days ago | neurologylive.com | Isabella Ciccone

Recently, Avadel Pharmaceuticals and nference announced the publication of real-world data in the Journal of Clinical Neuroscience, with results showing similar comorbidity profiles among patients with narcolepsy treated with immediate-release sodium oxybate (Xyrem) and those not treated with the drug.1,2 The retrospective analysis used de-identified electronic health records from Mayo Clinic to assess comorbidities and treatment patterns in 702 individuals with narcolepsy (treated with...
Common Idiopathic Intracranial Hypertension Drugs Show Modest Intracranial Pressure Reduction, With Noted Adverse Effects

6 days ago | neurologylive.com | Isabella Ciccone

A recently published randomized, cross-over extension trial in Headache reported that 4 drugs frequently used in idiopathic intracranial hypertension (IIH)—acetazolamide, furosemide, spironolactone, and topiramate—significantly reduced intracranial pressure (ICP) after 2 weeks of treatment, whereas amiloride did not show a significant effect.1 The analysis involved 14 women with active IIH who were treated in randomized order with the 5 different drugs over a 2-week period, separated by at...
Celebrating Innovation in MS Research With the John Dystel Prize: Bruce Bebo, PhD

6 days ago | neurologylive.com | Bruce F Bebo |Isabella Ciccone

WATCH TIME: 5 minutes “I think we’ll look back—when the cures are found for MS—and we’ll see these lectures at the Academy meeting as milestones and significant jumps in our understanding of MS that led to those cures.” The John Dystel Prize for Multiple Sclerosis Research, presented by the National Multiple Sclerosis Society (the Society) in partnership with the American Academy of Neurology (AAN), honors exceptional research that has significantly advanced the understanding, prevention,...
Expanding Access to Whole Genome Sequencing in Parkinson Research: James Beck, PhD

1 week ago | neurologylive.com | James Beck |Isabella Ciccone

WATCH TIME: 4 minutes“A key question we always get from [patients] with Parkinson is: if they don’t have a genetic form of Parkinson from a panel, do I still have Parkinson?
Migraine Treatment Zavegepant Shows No Meaningful Impact on Oral Contraceptive Exposure

1 week ago | neurologylive.com | Isabella Ciccone

In a phase 1 study published in Headache, investigators reported that multiple-dose intranasal zavegepant (Zavzpret; Pfizer), a calcitonin gene-related peptide receptor (CGRP) antagonist approved by the FDA for acute migraine treatment, did not meaningfully alter the pharmacokinetics of a single-dose oral contraceptive containing ethinyl estradiol and levonorgestrel in healthy adult women.1 The open-label, fixed-sequence study assessed whether zavegepant would affect exposure levels of...
Large Danish Cohort Study Reveals No Significant Association Between HLA Alleles and Migraine

1 week ago | neurologylive.com | Isabella Ciccone

A recent analysis of nearly 100,000 individuals from the Danish Blood Donor Study (DBDS) reported no significant genetic associations between migraine and the human leukocyte antigen (HLA) system, including across sex-specific or clinically defined migraine subtypes.
Advancements and Challenges in Pediatric Multiple Sclerosis Treatment: Lauren B. Krupp, MD

1 week ago | neurologylive.com | Lauren B. Krupp |Isabella Ciccone |Luke Halpern

WATCH TIME: 3 minutes"We now have therapies that are highly effective, and since young people with MS relapse or have clinical attacks more frequently than older people with MS, it's very important to get those therapies on board quickly."Pediatric multiple sclerosis (MS) is a chronic autoimmune disorder affecting the central nervous system, with onset occurring before the age of 18 years.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

X (formerly Twitter)

Followers: 134
Tweets: 320
DMs Open: No

Isabella Ciccone, MPH @iciccone7

17 Apr 25

RT @neurology_live: Take a look at NeurologyLive's latest feature📖: a sneak peek into Cleveland Clinic's upcoming Neurological Institute, a…

Isabella Ciccone, MPH @iciccone7

10 Apr 25

RT @neurology_live: 🙌🧠Thank you @AgneStraukiene for taking over the NeurologyLive X Channel during the 2025 #AANAM in San Diego, California…

Isabella Ciccone, MPH @iciccone7

8 Apr 25

RT @neurology_live: That’s wrap by Dr @AgneStraukiene from #AAN2025 in sunny San Diego! ☀️ From HSCT to Frexalimab, aging & DMTs—MS scienc…

Isabella Ciccone

Articles

FDA Grants Authorization to Epiminder’s Implantable Continuous EEG Monitor for Epilepsy Treatment

Final CHAMPION MG Trial Data Show Sustained Benefit, Safety of Ravulizumab in Myasthenia Gravis

Assessing Clinical Relevancy of Visual Biomarkers in Alzheimer Disease: Alfredo A. Sadun, MD, PhD

Real-World Data Show Similar Comorbidity Rates With and Without Sodium Oxybate Treatment

Common Idiopathic Intracranial Hypertension Drugs Show Modest Intracranial Pressure Reduction, With Noted Adverse Effects

Celebrating Innovation in MS Research With the John Dystel Prize: Bruce Bebo, PhD

Expanding Access to Whole Genome Sequencing in Parkinson Research: James Beck, PhD

Migraine Treatment Zavegepant Shows No Meaningful Impact on Oral Contraceptive Exposure

Large Danish Cohort Study Reveals No Significant Association Between HLA Alleles and Migraine

Advancements and Challenges in Pediatric Multiple Sclerosis Treatment: Lauren B. Krupp, MD

Contact details

Emails

Socials & Sites

X (formerly Twitter)